Aspirin Resistance in Obese and Elderly Patients with COVID-19?
Am J Med
.
2021 Apr;134(4):e297.
doi: 10.1016/j.amjmed.2020.09.006.
Authors
Kate Chander Chiang
1
,
Ajay Gupta
2
Affiliations
1
Scientist, KARE Biosciences, Las Vegas, Nevada.
2
Department of Medicine, School of Medicine, University of California Irvine, Irvine. Electronic address: ajayg1@hs.uci.edu.
PMID:
33888223
PMCID:
PMC8054641
DOI:
10.1016/j.amjmed.2020.09.006
No abstract available
Publication types
Letter
Comment
MeSH terms
Aged
Aspirin / therapeutic use
COVID-19*
Humans
Obesity
Outpatients
SARS-CoV-2*
Substances
Aspirin